Comparison of CRT-D and CRT-DX Systems (CRT-NEXT) — CRT-NEXT  

Heart Failure Clinical Trial

Official title: Non-inferiority Randomized Clinical Investigation of CRT-DX Versus CRT-D Systems

Status Recruiting

Clinical Trial Summary

The principal objective is to test non-inferiority of the CRT-DX system as compared to a conventional CRT-D system, in terms of the combined endpoint of mortality, hospitalizations due cardiovascular causes, any complication leading to loss of lead functionality, in the subset of patients without evidence of sinus dysfunction on optimal therapy.

Clinical Trial Description

Resting heart rate is strongly associated with incident worsening Heart Failure (HF) and mortality. Current devices for cardiac resynchronization (CRT-D) normally provide atrio-ventricular (AV) sequential pacing modes during resynchronization, but the best pacing programming strategy is not clear.

On the one hand a basic rate of 50 to 70 bpm (optionally with some rate-responsive function) could be considered for therapy up-titration, specifically betablockers; on the other hand, increasing pacing rates may partially reduce benefits from resynchronization, reducing filling time and contractility reservoir.

The Pegasus investigation is the only large randomized investigation comparing DDD with 70 bpm basic rate to DDD(R) @40 bpm. Results showed no difference in investigation endpoints, including mortality and HF-hospitalization.

These results may support the use of a device implementing both a CRT function and a right ventricular single-lead with and an atrial sensing dipole (CRT-DX system). This system can track ventricular pacing and resynchronization following atrial sensing, even if it cannot provide atrial pacing support. It should be assessed whether such limitation is counterbalanced by the advantages related to the reduced number of necessary leads, with simplified implantation and less complications.

The objective of the investigation is to assess whether atrial pacing support is really necessary in the subset of patients with indication to CRT-D and no evidence of sinus dysfunction on optimal therapy. The investigation will test the hypothesis that a CRT-DX system is not inferior to a conventional CRT-D system in this class of subjects. ;

Related Conditions & MeSH terms

• Cardiac Resynchronization Therapy
• Heart Failure

• NCT number: NCT03587064
• Study type: Interventional
• Source: Associazione Portatori Dispositivi Impiantabili Cardiaci
• Contact: Mauro Biffi, MD
• Phone: 0516363434
• Email: mbiffi64@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: October 22, 2018
• Completion date: April 2025